We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.46B
AUM Growth
+$49M
Cap. Flow
-$115M
Cap. Flow %
-7.85%
Top 10 Hldgs %
30.33%
Holding
150
New
19
Increased
27
Reduced
60
Closed
16

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$17M
2
ACM icon
Aecom
ACM
+$15.5M
3
MET icon
MetLife
MET
+$15.5M
4
SPGI icon
S&P Global
SPGI
+$14.5M
5
UNP icon
Union Pacific
UNP
+$13.6M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$20.9M
2
GIS icon
General Mills
GIS
+$20.9M
3
UNH icon
UnitedHealth
UNH
+$18.2M
4
CB icon
Chubb
CB
+$17.9M
5
ABBV icon
AbbVie
ABBV
+$17.3M

Sector Composition

Rank Sector Weight
1 Financials 13.92%
2 Technology 11.39%
3 Industrials 11.14%
4 Energy 10.8%
5 Healthcare 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
1
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$190M 12.99%
+25,800
New +$1.93M
AJG icon
2
Arthur J. Gallagher & Co
AJG
$63.7B
$32.3M 2.21%
141,760
-4,100
-3% -$918K
MSFT icon
3
Microsoft
MSFT
$2.84T
$31.6M 2.16%
100,130
+38,600
+63% +$12.8M
XOM icon
4
ExxonMobil
XOM
$651B
$30.1M 2.05%
255,650
-76,200
-23% -$8.36M
JPM icon
5
JPMorgan Chase
JPM
$939B
$28.5M 1.95%
196,680
+5,400
+3% +$809K
AMP icon
6
Ameriprise Financial
AMP
$46.8B
$28.4M 1.94%
86,090
-1,580
-2% -$539K
CMCSA icon
7
Comcast
CMCSA
$79.1B
$27M 1.85%
609,730
-94,240
-13% -$4.21M
MCD icon
8
McDonald's
MCD
$188B
$26.9M 1.84%
102,100
+19,500
+24% +$5.56M
ACM icon
9
Aecom
ACM
$9.07B
$24.7M 1.69%
297,070
+179,570
+153% +$15.5M
CVX icon
10
Chevron
CVX
$388B
$24.4M 1.66%
144,510
-2,400
-2% -$388K
IVW icon
11
iShares S&P 500 Growth ETF
IVW
$72.5B
$23.1M 1.57%
336,899
-285
-0.1% -$20.2K
EPD icon
12
Enterprise Products Partners
EPD
$83.8B
$22.8M 1.56%
832,370
+81,100
+11% +$2.17M
V icon
13
Visa
V
$677B
$21M 1.43%
91,300
+20,800
+30% +$5M
AVGO icon
14
Broadcom
AVGO
$1.82T
$20.9M 1.43%
252,100
-72,000
-22% -$6.24M
META icon
15
Meta Platforms (Facebook)
META
$1.51T
$19.8M 1.35%
66,010
-1,700
-3% -$512K
CVS icon
16
CVS Health
CVS
$137B
$19.8M 1.35%
283,400
+182,000
+179% +$12.9M
PLD icon
17
Prologis
PLD
$138B
$19.8M 1.35%
176,100
-5,400
-3% -$661K
COST icon
18
Costco
COST
$415B
$19.5M 1.33%
34,590
-8,500
-20% -$4.69M
SPY icon
19
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$19M 1.3%
44,362
+1,210
+3% +$538K
DOV icon
20
Dover
DOV
$27.2B
$18.9M 1.29%
135,480
-2,200
-2% -$318K
COP icon
21
ConocoPhillips
COP
$147B
$18.7M 1.27%
155,800
+146,600
+1,593% +$17M
DOX icon
22
Amdocs
DOX
$5.53B
$18.3M 1.25%
216,300
-47,000
-18% -$4.25M
GXO icon
23
GXO Logistics
GXO
$6.06B
$18.3M 1.25%
311,550
+90,750
+41% +$5.68M
ZTS icon
24
Zoetis
ZTS
$31.6B
$18M 1.23%
103,590
-2,500
-2% -$454K
CARR icon
25
Carrier Global
CARR
$57.2B
$17.6M 1.2%
319,170
-1,500
-0.5% -$82.5K

Similar funds

Payden & Rygel's Q3 2023 Portfolio in Review

As of Q3 2023, Payden & Rygel held 150 positions worth $1.46B, up 3.5% from $1.42B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Payden & Rygel withdrew a net $115M in Q3 2023, closing 16 positions and reducing 60 holdings. Its most notable exit was RTX Corp, an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Payden & Rygel opened a new position in MetLife worth $15.6M.

  • Payden & Rygel's largest Q3 2023 buy was MetLife: 248,300 shares worth $15.6M.
  • Payden & Rygel added most to ConocoPhillips in Q3 2023, an estimated $17M increase.
  • Payden & Rygel's biggest Q3 2023 reduction was UnitedHealth, cutting an estimated $18.2M.
  • Payden & Rygel fully exited RTX Corp in Q3 2023, selling an estimated $20.9M.
  • Payden & Rygel's ten largest holdings make up 30% of its $1.46B portfolio in Q3 2023.
  • Payden & Rygel opened 19 new positions and closed 16 in Q3 2023.
  • Payden & Rygel's portfolio value rose 3.5% quarter-over-quarter to $1.46B.

Based on Payden & Rygel's 13F filing for Q3 2023, filed 7 Oct 2024.